PUBLISHER: Value Market Research | PRODUCT CODE: 1498667
PUBLISHER: Value Market Research | PRODUCT CODE: 1498667
Global Cardiac Troponin Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
The global demand for Cardiac Troponin Market is presumed to reach the market size of nearly USD 11.17 Billion by 2032 from USD 4.95 Billion in 2023 with a CAGR of 9.46% under the study period 2024-2032.
Cardiac troponin is a protein complex in heart muscle cells crucial for muscle contraction. It comprises three subunits: troponin T, troponin I, and troponin C. Elevated levels of this protein in the blood are a key biomarker for diagnosing myocardial infarction (heart attack). When heart muscle cells incur damage, troponin is released into the bloodstream, rendering it a highly sensitive and specific marker for heart injury. Measuring levels helps healthcare providers assess the severity of a heart attack and guide treatment decisions. It is a vital tool in emergency medicine & cardiology for the early detection of acute coronary syndromes.
MARKET DYNAMICS
The cardiac troponin market is influenced by the increasing prevalence of cardiovascular diseases worldwide, such as myocardial infarction and heart failure. Rising disease burden, aging populations, and unhealthy lifestyles drive market growth. Advancements in medical technology and laboratory diagnostics have led to the development of exceptional sensitive troponin assays, enabling earlier and more accurate detection of myocardial injury. These technological innovations enhance patient care and drive market adoption. Additionally, the increasing emphasis on preventive healthcare and routine cardiac screening among high-risk populations further boosts the demand for cardiac troponin. Moreover, the expanding application of troponin assays beyond acute coronary syndromes to include conditions like heart failure and sepsis broadens the market's scope and potential. Efforts by the government to enhance healthcare infrastructure and accessibility to diagnostic services bolster market expansion by augmenting the availability and affordability of troponin testing. However, the need for highly sensitive diagnostic equipment and potential false-positive results may challenge the cardiac troponin market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Troponin. The growth and trends of Cardiac Troponin industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Cardiac Troponin market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Troponin Type
- Troponin I
- Troponin T
- Troponin C
By Setting
- Laboratory Setting
- Point-of-Care (POC) Testing
By Indication
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Others (Cardiomyopathy, etc.)
By End-user
- Hospitals & Clinics
- Diagnostic Laboratories
- Homecare Settings
- Others (research Institutes, etc.)
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Cardiac Troponin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Troponin market include F. Hoffmann-La Roche Ltd., BioMeRieux SA, Abbott Laboratories, Siemens Healthineers India, Eurolyser Diagnostica GmbH, QuidelOrtho Corporation, Beckman Coulter Inc., Response Biomedical Corporation, LifeSign LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. CARDIAC TROPONIN - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Troponin Type
- 3.7.2 Market Attractiveness Analysis By Setting
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL CARDIAC TROPONIN MARKET ANALYSIS BY TROPONIN TYPE
- 5.1. Overview By Troponin Type
- 5.2. Historical and Forecast Data Analysis By Troponin Type
- 5.3. Troponin I Historic and Forecast Sales By Regions
- 5.4. Troponin T Historic and Forecast Sales By Regions
- 5.5. Troponin C Historic and Forecast Sales By Regions
6. GLOBAL CARDIAC TROPONIN MARKET ANALYSIS BY SETTING
- 6.1. Overview By Setting
- 6.2. Historical and Forecast Data Analysis By Setting
- 6.3. Laboratory Setting Historic and Forecast Sales By Regions
- 6.4. Point-of-Care (POC) Testing Historic and Forecast Sales By Regions
7. GLOBAL CARDIAC TROPONIN MARKET ANALYSIS BY INDICATION
- 7.1. Overview By Indication
- 7.2. Historical and Forecast Data Analysis By Indication
- 7.3. Myocardial Infarction Historic and Forecast Sales By Regions
- 7.4. Congestive Heart Failure Historic and Forecast Sales By Regions
- 7.5. Acute Coronary Syndrome Historic and Forecast Sales By Regions
- 7.6. Others (Cardiomyopathy, etc.) Historic and Forecast Sales By Regions
8. GLOBAL CARDIAC TROPONIN MARKET ANALYSIS BY END-USER
- 8.1. Overview By End-user
- 8.2. Historical and Forecast Data Analysis By End-user
- 8.3. Hospitals & Clinics Historic and Forecast Sales By Regions
- 8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
- 8.5. Homecare Settings Historic and Forecast Sales By Regions
- 8.6. Others (research Institutes, etc.) Historic and Forecast Sales By Regions
9. GLOBAL CARDIAC TROPONIN MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE CARDIAC TROPONIN COMPANIES
- 10.1. Cardiac Troponin Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11. COMPANY PROFILES OF CARDIAC TROPONIN INDUSTRY
- 11.1. Top Companies Market Share Analysis
- 11.2. Market Concentration Rate
- 11.3. F. Hoffmann-La Roche Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
- 11.4. BioMeRieux SA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
- 11.5. Abbott Laboratories
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
- 11.6. Siemens Healthineers India
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
- 11.7. Eurolyser Diagnostica GmbH
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
- 11.8. QuidelOrtho Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
- 11.9. Beckman Coulter Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
- 11.10. Response Biomedical Corporation
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
- 11.11. LifeSign LLC
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Troponin Type (USD MN)
- Troponin I Market Sales By Geography (USD MN)
- Troponin T Market Sales By Geography (USD MN)
- Troponin C Market Sales By Geography (USD MN)
- Analysis By Setting (USD MN)
- Laboratory Setting Market Sales By Geography (USD MN)
- Point-of-Care (POC) Testing Market Sales By Geography (USD MN)
- Analysis By Indication (USD MN)
- Myocardial Infarction Market Sales By Geography (USD MN)
- Congestive Heart Failure Market Sales By Geography (USD MN)
- Acute Coronary Syndrome Market Sales By Geography (USD MN)
- Others (Cardiomyopathy, etc.) Market Sales By Geography (USD MN)
- Analysis By End-user (USD MN)
- Hospitals & Clinics Market Sales By Geography (USD MN)
- Diagnostic Laboratories Market Sales By Geography (USD MN)
- Homecare Settings Market Sales By Geography (USD MN)
- Others (research Institutes, etc.) Market Sales By Geography (USD MN)
- Global Cardiac Troponin Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Cardiac Troponin Report
- Market Research Process
- Market Research Methodology
- Global Cardiac Troponin Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Troponin Type
- Market Attractiveness Analysis By Setting
- Market Attractiveness Analysis By Indication
- Market Attractiveness Analysis By End-user
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Troponin Type (USD MN)
- Troponin I Market Sales By Geography (USD MN)
- Troponin T Market Sales By Geography (USD MN)
- Troponin C Market Sales By Geography (USD MN)
- Global Market Analysis By Setting (USD MN)
- Laboratory Setting Market Sales By Geography (USD MN)
- Point-of-Care (POC) Testing Market Sales By Geography (USD MN)
- Global Market Analysis By Indication (USD MN)
- Myocardial Infarction Market Sales By Geography (USD MN)
- Congestive Heart Failure Market Sales By Geography (USD MN)
- Acute Coronary Syndrome Market Sales By Geography (USD MN)
- Others (Cardiomyopathy, etc.) Market Sales By Geography (USD MN)
- Global Market Analysis By End-user (USD MN)
- Hospitals & Clinics Market Sales By Geography (USD MN)
- Diagnostic Laboratories Market Sales By Geography (USD MN)
- Homecare Settings Market Sales By Geography (USD MN)
- Others (research Institutes, etc.) Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
